COVID-19大流行对日本重症监护资源利用的影响:一项全国住院数据库研究
本研究利用日本诊断程序组合住院数据库,纳入2019年2月9日至2021年2月8日所有入住ICU或HDU的患者,以2020年2月9日为界比较COVID-19前后重症监护服务利用情况。结果显示,COVID-19期间ICU患者数由297,679降至277,799,HDU患者数由408,005降至384,647;383所ICU医院中仅14所(3.7%)增加ICU床位,460所HDU医院中仅33所(7.2%)增加HDU床位。中断时间序列分析显示ICU床位占用率出现下降的水平变化(-4.29%,95%CI -5.69至-2.88%),HDU呈相似趋势。作者结论认为,日本COVID-19期间ICU/HDU床位容量未增加而占用率下降,临床医生放弃ICU/HDU治疗的决定未改变,重症COVID-19患者的中心化亦无进展。
要点
- COVID-19期间日本ICU床位占用率较前下降,中断时间序列分析水平变化为-4.29%(95%CI -5.69至-2.88%),HDU呈相似趋势。
- 383所ICU医院中仅14所(3.7%)增加ICU床位,460所HDU医院中仅33所(7.2%)增加HDU床位,容量基本未扩。
- ICU患者数由297,679降至277,799,HDU患者数由408,005降至384,647,患者特征与结局除COVID-19病因外相似。
- 383所ICU医院中232所(60.6%)在ICU收治COVID-19患者,年ICU COVID-19病例量差异极大,中位数10例(IQR 3-25,最小1,最大444)。
- 作者结论认为,临床医生放弃ICU/HDU治疗的决定未改变,重症COVID-19患者的中心化亦无进展。
适用人群与场景
- 2019年2月9日至2021年2月8日期间入住ICU或HDU的所有患者,数据来自日本诊断程序组合住院数据库。
- 参与医院包括383所配备ICU的医院和460所配备HDU的医院。
研究设计与关键结果
- 研究类型:基于全国住院行政数据库的研究;以2020年2月9日为界比较COVID-19前后两个时期。
- ICU患者数COVID-19前297,679例 vs 期间277,799例;HDU患者数前408,005例 vs 期间384,647例。
- 383所ICU医院中增加ICU床位者14所(3.7%),460所HDU医院中增加HDU床位者33所(7.2%)。
- ICU和HDU的患者特征与结局在COVID-19前后相似,唯一例外是收治主要病因中出现了COVID-19。
- ICU平均床位占用率COVID-19前51.5% vs 期间47.5%;中断时间序列分析显示期间ICU床位占用率出现下降的水平变化(-4.29%,95%CI -5.69至-2.88%),HDU床位占用率呈相似趋势。
- 383所ICU医院中232所(60.6%)在ICU收治COVID-19患者;其年ICU COVID-19病例量差异很大,中位数10例(四分位距3-25,最小1,最大444)。
证据类型、等级与局限
- 证据类型:基于全国住院行政数据库的观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 研究显示COVID-19期间日本ICU和HDU床位容量未增加而床位占用率下降,提示临床医生放弃ICU/HDU治疗的决定未改变,重症COVID-19患者的中心化亦无进展。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has disrupted critical care services worldwide. Examining how critical care systems responded to the COVID-19 pandemic on a national level will be useful in setting future critical care plans. The present study aimed to describe the utilization of critical care services before and during the COVID-19 pandemic using a nationwide Japanese inpatient administrative database.
METHODS: All patients admitted to an intensive care unit (ICU) or a high-dependency care unit (HDU) from February 9, 2019, to February 8, 2021, in the Japanese Diagnosis Procedure Combination inpatient database were included. February 9, 2020, was used as the breakpoint separating the periods before and during COVID-19 pandemic. Hospital and patient characteristics were compared before and during the COVID-19 pandemic. Change in ICU and HDU bed occupancy before and during the COVID-19 pandemic was evaluated using interrupted time-series analysis.
RESULTS: The number of ICU patients before and during the COVID-19 pandemic was 297,679 and 277,799, respectively, and the number of HDU patients was 408,005 and 384,647, respectively. In the participating hospitals (383 ICU-equipped hospitals and 460 HDU-equipped hospitals), the number of hospitals which increased the ICU and HDU beds capacity were 14 (3.7%) and 33 (7.2%), respectively. Patient characteristics and outcomes in ICU and HDU were similar before and during the COVID-19 pandemic except main etiology for admission of COVID-19. The mean ICU bed occupancy before and during the COVID-19 pandemic was 51.5% and 47.5%, respectively. The interrupted time-series analysis showed a downward level change in ICU bed occupancy during the COVID-19 pandemic (- 4.29%, 95% confidence intervals - 5.69 to - 2.88%), and HDU bed occupancy showed similar trends. Of 383 hospitals with ICUs, 232 (60.6%) treated COVID-19 patients in their ICUs. Their annual hospital case volume of COVID-19 ICU patients varied greatly, with a median of 10 (interquartile range 3-25, min 1, max 444).
CONCLUSIONS: The ICU and HDU bed capacity did not increase while their bed occupancy decreased during the COVID-19 pandemic in Japan. There was no change in clinicians' decision-making to forego ICU/HDU care for selected patients, and there was no progress in the centralization of critically ill COVID-19 patients.
参考来源
- Ohbe H, Sasabuchi Y, Matsui H, et al. Impact of the COVID-19 pandemic on critical care utilization in Japan: a nationwide inpatient database study. J Intensive Care. 2022. PMID: 36461111. doi:10.1186/s40560-022-00645-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。